Alkermes shareholders approve 5.9 million share increase for equity incentive plan
At its May 20, 2026 annual general meeting, Alkermes shareholders elected nine directors to one-year terms, approved amendments to the 2018 Stock Option and Incentive Plan that add 5,900,000 ordinary shares for issuance, and ratified PricewaterhouseCoopers LLP as independent auditor. The plan amendment drew 12,952,836 votes against, and the filing reports no change in executive officers. The larger share reserve gives the company more room to make equity awards, which can dilute existing shareholders.
Key points
- Shareholders approved amendments to the 2018 Stock Option and Incentive Plan, increasing authorized ordinary shares by 5,900,000 at the May 20, 2026 meeting.
- The plan was approved with 128,147,910 votes for, 12,952,836 against, and 69,229 abstentions.
- All nine director nominees were elected to one-year terms ending at the 2027 annual general meeting; say-on-pay passed with 139,234,176 votes for and 1,787,311 against.
- PricewaterhouseCoopers LLP was ratified as independent auditor with 146,222,286 votes for and 2,812,663 against.
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.